AMED Co (ROCO:7575) Debt-to-Revenue : 0.31 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is AMED Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

AMED Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$112.0 Mil. AMED Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$145.4 Mil. AMED Co's annualized Revenue for the quarter that ended in Dec. 2023 was NT$824.5 Mil. AMED Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.31.

AMED Co Debt-to-Revenue Historical Data

The historical data trend for AMED Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AMED Co Debt-to-Revenue Chart

AMED Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

0.67

0.56

0.54

0.42

0.34

AMED Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial				0.51	0.52	0.38	0.39	0.31

Competitive Comparison of AMED Co's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, AMED Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AMED Co's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AMED Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where AMED Co's Debt-to-Revenue falls into.

AMED Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

AMED Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(111.975	+	145.416)	/	763.823
	=	0.34

AMED Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(111.975	+	145.416)	/	824.496
	=	0.31

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.

AMED Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of AMED Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

AMED Co (ROCO:7575) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AMED Co Ltd (ROCO:7575) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 14, Wuquan 7th Road, 4th Floor, Wugu District, New Taipei, TWN

Website

https://www.amed.com.tw

AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.

AMED Co (ROCO:7575) Headlines

No Headlines